Alibaba Health Information Technology (HKSE:00241) 3-Year EBITDA Growth Rate : 95.10% (As of Sep. 2023)

View and export this data going back to 1972. Start your Free Trial

What is Alibaba Health Information Technology 3-Year EBITDA Growth Rate?

Alibaba Health Information Technology's EBITDA per Share for the six months ended in Sep. 2023 was HK$0.04.

During the past 12 months, Alibaba Health Information Technology's average EBITDA Per Share Growth Rate was 270.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 95.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Alibaba Health Information Technology was 95.10% per year. The lowest was -78.30% per year. And the median was -46.80% per year.

Competitive Comparison of Alibaba Health Information Technology's 3-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alibaba Health Information Technology's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's 3-Year EBITDA Growth Rate falls into.

Alibaba Health Information Technology 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Alibaba Health Information Technology (HKSE:00241) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Alibaba Health Information Technology 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Alibaba Health Information Technology's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Alibaba Health Information Technology (HKSE:00241) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Alibaba Health Information Technology Ltd (HKSE:00241) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

ALBBY:USA ALBHF:USA TWY:Germany

Address

Guanghua Road, 65/F, CITIC Tower, Building 1, No.10, Jianwai Subdistrict, Chaoyang District, Beijing, CHN

Website

https://www.alihealth.cn

Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

Alibaba Health Information Technology (HKSE:00241) Headlines

No Headlines